Heterocyclic compounds as inhibitors of the sodium iodide symporter
申请人:COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX
ENERGIES ALTERNATIVES
公开号:EP2738173A1
公开(公告)日:2014-06-04
The invention relates to new compounds of formula (I):
for their use as medicaments, and in particular as inhibitors of sodium iodide symporter (NIS) and reducers of iodine transport and/or accumulation into NIS-expressing cells. The invention also relates to a pharmaceutical composition comprising at least one compound of formula (I) as active principle. Finally, the present invention relates to specific compounds of formula (I) as such.
[EN] HETEROCYCLIC COMPOUNDS AS INHIBITORS OF THE SODIUM IODIDE SYMPORTER<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES COMME INHIBITEURS DU SYMPORT SODIUM/IODURE
申请人:COMMISSARIAT ENERGIE ATOMIQUE
公开号:WO2014083529A1
公开(公告)日:2014-06-05
The invention relates to new compounds of formula (I): for their use as medicaments, for inhibiting sodium iodide symporter (NIS), and in particular for reducing iodine transport and/or accumulation into NIS-expressing cells. The invention also relates to a pharmaceutical composition comprising at least one compound of formula (I) as active principle. Finally, the present invention relates to specific compounds of formula (I) as such.
Heterocyclic Compounds As Inhibitors Of The Sodium Iodide Symporter
申请人:COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
公开号:US20150299218A1
公开(公告)日:2015-10-22
The invention relates to new compounds of formula (I):
for their use as medicaments, for inhibiting sodium iodide symporter (NIS), and in particular for reducing iodine transport and/or accumulation into NIS-expressing cells. The invention also relates to a pharmaceutical composition having at least one compound of formula (I) as active principle. Finally, the present invention relates to specific compounds of formula (I) as such.